md phd: audio

Pick anything below and it plays in the bar at the foot of the window — and keeps playing while you go on browsing the directory.

1. 1▶Raj Chovatiya, MD, PhD, MSCI - In Your Hands: A Case-Based Approach to Treating Moderate-to-Severe Chronic Hand EczemaPeerVoice Endocrinology & Metabolic Disorders Audio23:38Notes
   +Listen later
2. 2▶Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic AdvancementPeerVoice Clinical Pharmacology Audio19:20Notes
   +Listen later
3. 3▶Amarnath Challapalli, MBBS, MD (RT), MRCP, FRCR, PhD, FRCP / Amer Durrani, FRCS (Plast) - Partnering With Patients in High-Risk CSCC: Redefining the Surgical Paradigm to Optimise Clinical and Patient OutcomesPeerVoice Clinical Pharmacology Audio32:12Notes
   +Listen later
4. 4▶Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic AdvancementPeerVoice Brain & Behaviour Audio19:20Notes
   +Listen later
5. 5▶One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Clinical Pharmacology Audio26:33Notes
   +Listen later
6. 6▶John Friedewald, MD, FASN, FAST - Breakthroughs and Buzz From Boston: Key Takeaways for the Kidney Transplant CommunityPeerVoice Clinical Pharmacology Audio17:39Notes
   +Listen later
7. 7▶Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and ManagementPeerVoice Clinical Pharmacology Audio16:39Notes
   +Listen later
8. 8▶One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Brain & Behaviour Audio26:33Notes
   +Listen later
9. 9▶Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and ManagementPeerVoice Heart & Lung Audio16:39Notes
   +Listen later
10. 10▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Endocrinology & Metabolic Disorders Audio1:17:14Notes
    +Listen later
11. 11▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Clinical Pharmacology Audio1:17:14Notes
    +Listen later
12. 12▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Heart & Lung Audio1:17:14Notes
    +Listen later
13. 13▶Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic DiseasePeerVoice Endocrinology & Metabolic Disorders Audio25:41Notes
    +Listen later
14. 14▶Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic DiseasePeerVoice Clinical Pharmacology Audio25:41Notes
    +Listen later
15. 15▶David Alain Wohl, MD - From Guidelines to Ground Truth: The Reality of Rapid ART in the Real WorldPeerVoice Immunology & Infectious Disease Audio20:43Notes
    +Listen later
16. 16▶David Alain Wohl, MD - From Guidelines to Ground Truth: The Reality of Rapid ART in the Real WorldPeerVoice Clinical Pharmacology Audio20:43Notes
    +Listen later
17. 17▶Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances EmergePeerVoice Clinical Pharmacology Audio18:45Notes
    +Listen later
18. 18▶Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast CancerPeerVoice Clinical Pharmacology Audio19:41Notes
    +Listen later
19. 19▶Georgios Tsivgoulis, MD, PhD, MSc - Navigating the Latest Evidence Surrounding Current and Emerging Strategies for Secondary Stroke PreventionPeerVoice Brain & Behaviour Audio20:17Notes
    +Listen later
20. 20▶Silvia Messina, MD, DPhil / Michael Levy, MD, PhD - Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) or Something Else? How to Tell the DifferencePeerVoice Brain & Behaviour Audio29:54Notes
    +Listen later
21. 21▶Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday PracticePeerVoice Endocrinology & Metabolic Disorders Audio35:42Notes
    +Listen later
22. 22▶Anjali Tiku Owens, MD - Contemporary Data, Differentiation, and Decision-Making in Hypertrophic Cardiomyopathy: A Guide to Cardiac Myosin Inhibition for the Managed Care ProfessionalPeerVoice Heart & Lung Audio1:20:09Notes
    +Listen later
23. 23▶Mike Sharma, MD, MSc, FRCPC - Deepening the Dialogue on the Latest Data for Factor XIa Inhibition: Is It Time to Shift the Paradigm in Secondary Stroke Prevention?PeerVoice Brain & Behaviour Audio1:15:47Notes
    +Listen later
24. 24▶Colin M. Dayan, MA, MBBS, FRCP, PhD - Innovation Through Immunomodulation: The Practicalities of Delaying the Progression of Type 1 DiabetesPeerVoice Endocrinology & Metabolic Disorders Audio1:19:25Notes
    +Listen later
25. 25▶Javier Ampuero, MD, PhD - Making MASH a Priority in Our Gastroenterology Practices: Why We Should and How We CanPeerVoice Endocrinology & Metabolic Disorders Audio20:02Notes
    +Listen later
26. 26▶Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa InhibitionPeerVoice Brain & Behaviour Audio36:53Notes
    +Listen later
27. 27▶Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa InhibitionPeerVoice Heart & Lung Audio36:53Notes
    +Listen later
28. 28▶Caterina Garone, MD, PhD - From Clinical Clues to a Confirmatory Diagnosis: Recognising Thymidine Kinase 2 Deficiency Across the Age SpectrumPeerVoice Brain & Behaviour Audio27:58Notes
    +Listen later
29. 29▶Ashkan Shoamanesh, MD, FRCPC - Turning Pathophysiologic Promise Into Evidence-Based Potential: Are Factor XIa Inhibitors Ready for Prime Time in Secondary Stroke Prevention?PeerVoice Brain & Behaviour Audio1:10:40Notes
    +Listen later
30. 30▶Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy EraPeerVoice Heart & Lung Audio40:01Notes
    +Listen later
31. 31▶Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established TherapiesPeerVoice Immunology & Infectious Disease Audio21:52Notes
    +Listen later
32. 32▶Yohei Doi, MD, PhD - Know the Risk, Act on Evidence: Strategic Interventions in COVID-19 Care of High-Risk PatientsPeerVoice Immunology & Infectious Disease Audio28:36Notes
    +Listen later
33. 33▶Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established TherapiesPeerVoice Endocrinology & Metabolic Disorders Audio21:52Notes
    +Listen later
34. 34▶Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established TherapiesPeerVoice Heart & Lung Audio21:52Notes
    +Listen later
35. 35▶Ira Goldberg, MD - Mastering the Fundamentals of Care for Chylomicronemia: Following the Patient Care Pathway From Differential Diagnosis to Modern ManagementPeerVoice Endocrinology & Metabolic Disorders Audio29:06Notes
    +Listen later
36. 36▶Ira Goldberg, MD - Mastering the Fundamentals of Care for Chylomicronemia: Following the Patient Care Pathway From Differential Diagnosis to Modern ManagementPeerVoice Heart & Lung Audio29:06Notes
    +Listen later
37. 37▶Sara Mariotto, MD, PhD - Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other Rare Neuroimmunological Disorders?PeerVoice Brain & Behaviour Audio16:18Notes
    +Listen later
38. 38▶Ira Goldberg, MD - The Expanding Treatment Landscape for Familial Chylomicronemia Syndrome: Exploring New Options and OpportunitiesPeerVoice Endocrinology & Metabolic Disorders Audio9:49Notes
    +Listen later
39. 39▶Ira Goldberg, MD - The Expanding Treatment Landscape for Familial Chylomicronemia Syndrome: Exploring New Options and OpportunitiesPeerVoice Heart & Lung Audio9:49Notes
    +Listen later
40. 40▶John E. Anderson, MD / Richard J. Auchus, MD, PhD - Hypercortisolism and Difficult-to-Treat Cardiometabolic Disease: Therapeutic Developments and Clinical Advances Driving Meaningful Improvement in Patient OutcomesPeerVoice Endocrinology & Metabolic Disorders Audio30:19Notes
    +Listen later
41. 41▶John E. Anderson, MD / Richard J. Auchus, MD, PhD - Hypercortisolism and Difficult-to-Treat Cardiometabolic Disease: Therapeutic Developments and Clinical Advances Driving Meaningful Improvement in Patient OutcomesPeerVoice Heart & Lung Audio30:19Notes
    +Listen later
42. 42▶Colin Russell, PhD / John Watkins, MBBCh, BSc - A Shot in the Arm: Leveraging Combination Vaccines for Global Health ImpactPeerVoice Immunology & Infectious Disease Audio17:26Notes
    +Listen later
43. 43▶Colin Russell, PhD / John Watkins, MBBCh, BSc - A Shot in the Arm: Leveraging Combination Vaccines for Global Health ImpactPeerVoice Brain & Behaviour Audio17:26Notes
    +Listen later
44. 44▶Erwan Donal, MD, PhD / Nina Ajmone Marsan, MD, PhD - At the Cutting Edge of ATTR-CM: How Can We Leverage Advances in Multimodality Cardiac Imaging and Artificial Intelligence to Modernise Diagnosis and Monitoring?PeerVoice Heart & Lung Audio29:14Notes
    +Listen later
45. 45▶JAK Inhibition and the Future of HS TreatmentDermDocs37:33Notes
    +Listen later
46. 46▶Metastatic Recurrence Among Adolescents and Young Adults With CancerJAMA Oncology Author Interviews11:52Notes
    +Listen later
47. 47▶David Alain Wohl, MD - Inpatient Management of SARS-CoV-2 Infection: Applying Learnings From Real World Evidence to Real World PracticePeerVoice Immunology & Infectious Disease Audio38:52Notes
    +Listen later
48. 48▶Nancy Carteron, MD, FACR - Congress Insights Direct From Chicago: The Need-to-Knows on B Cell–Targeting in Sjögren’s DiseasePeerVoice Immunology & Infectious Disease Audio19:49Notes
    +Listen later
49. 49▶Moving into the Non-Steroidal Topical Therapy AgeDermDocs29:55Notes
    +Listen later
50. 50▶Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and MortalityJAMA Oncology Author Interviews12:29Notes
    +Listen later